Cargando…
Seroprevalence and T‐cell response in 32 children 10 months after COVID‐19
Autores principales: | Moritz, David, Krifors, Anders, Freyhult, Elisabeth, Månsson, Emeli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111266/ https://www.ncbi.nlm.nih.gov/pubmed/35150457 http://dx.doi.org/10.1111/apa.16287 |
Ejemplares similares
-
No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study
por: Granstam, Elisabet, et al.
Publicado: (2021) -
Seroprevalence and vaccine responses
por: Wadia, Reena
Publicado: (2021) -
High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19
por: Ahmad, Irma, et al.
Publicado: (2023) -
OL-044 HAV seroprevalence among children with 10 24 month ages in Ulaanbaatar
por: Sarangua, G., et al.
Publicado: (2008) -
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
por: Stubblefield, William B, et al.
Publicado: (2020)